Home

First Time Patients

Find suggestions for your first appointment to help you get started. 

Read more...

Success Rates

Read about the very latest OU Physicians Reproductive Medicine success rates. 

Read more...

Meet our Specialists

OURM has the most Infertility specialists in the state of Oklahoma!

Read more.....

Financial Info

Set your mind at ease by determining your coverage in advance.

Read more...

Pardis Hosseinzadeh, MD

Arya2018

 

 

 

 

 

 

 

 

 

 

Specialties-Reproductive Endocrinology & Infertility Fellow:

  • Assisted Reproductive Technologies, including IVF
  • Premature Ovarian Failure
  • Reproductive surgery
  • Uterine anomalies
  • Menstrual cycle abnormalities including polycystic ovarian syndrome
  • Donor egg and donor sperm
  • Pediatric and Adolescent Gynecology

Licensure:

  • State of Oklahoma, 2020- present
  • State of Texas 2016-2020
  • State of California 2018- present

Education/Work –

  • Medical Doctorate at Isfahan University of Medical Science, Isfahan, Iran, 2005-2012
  • PostDoc Research Fellow, Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas 2014-2016
  • Residency in Obstetrics and Gynecology at Baylor College of Medicine, Houston, Texas, 2016-2020
  • Fellowship in Reproductive Endocrinology and Infertility at University of Oklahoma, 2020- present

Languages:

English, Spanish, Farsi

Research Interests:

  • Polycystic Ovarian Syndrome (PCOS): Involvement of genetic and epigenetic in the development of PCOS, effects on uterus and endometrium
  • Assisted reproductive technologies, including IVF

Affiliations:

Honors (selected):

  • 2019   Pacific Coast Reproductive Society Scholarship recipient
  • 2018   Resident Research Day Award – Baylor College of Medicine, Houston, Texas.

Peer reviewed publications:

  • Hosseinzadeh P, Ghahiri A, Daneshmand F, Ghasemi M. A comparative study of vaginal estrogen cream and sustained-release estradiol vaginal tablet (Vagifem) in the treatment of atrophic vaginitis in Isfahan, Isfahan Province, Iran in 2010-2012. J Res Med Sci. 2015 Dec;20(12):1160-5. doi: 10.4103/1735-1995.172983. PubMed PMID: 26958050
  • Hosseinzadeh P, Shamshirsaz A.A, Javadian P, Espinoza J, Gandhi M, Ruano R, Cass D.L, Olutoye O.A, Belfort M.A. Prenatal Therapy of Large Placental Chorioangiomas: Case Report and Review of the Literature. American Journal of Perinatology
Reports. 2015, Oct; 5(2): e196-202.

  • Hosseinzadeh P, Shamshirsaz A.A, Cass D.L, Espinoza J, Lee W, Salmanian B, Ruano R, Belfort M.A,(2015, January 22). Fetoscopic laser ablation of vasa previa for a fetus with a giant
cervical lymphatic malformation. Ultrasound Obstet Gynecol. 2015 Oct;46(4):507-8.doi: 10.1159/000475990. [Epub ahead of print]

  • Bateni ZH, Clark SL, Sangi-Haghpeykar H, Aagaard KM, Blumenfeld YJ, Ramin SM, Lee HC, Fox KA, Moaddab A, Shamshirsaz AA, Salmanian B, Hosseinzadeh P, Racusin DA, Erfani H, Espinoza J, Dildy GA, Belfort MA, Shamshirsaz AA. Trends in the delivery route of twin pregnancies in the United States, 2006-2013. Eur J Obstet Gynecol Reprod Biol. 2016 Oct;205:120-6.

  • Nassr AA, Ness A, Hosseinzadeh P, Salmanian B, Espinoza J, Berger V, Werner E, Erfani H, Welty S, Bateni ZH, Shamshirsaz AA, Popek E, Ruano R, Davis AS, Lee TC, Keswani S, Cass DL, Olutoye OO, Belfort MA, Shamshirsaz AA. Outcome and Treatment of Antenatally Diagnosed Nonimmune Hydrops Fetalis. Fetal Diagn Ther. 2018; 43(2):123-128. doi: 10.1159/000475990. Epub 2017 Jun 24.

  • Shamshirsaz AA, Bateni ZH, Sangi-Haghpeykar H, Arian SE, Erfani H, Shamshirsaz AA, Abuhamad A, Fox KA, Ramin SM, Moaddab A, Maskatia SA, Salmanian B, Lopez KN, Hosseinzadeh P, Schutt AK, Nassr AA, Espinoza J, Dildy GA, Belfort MA, Clark SL. Cyanotic congenital heart disease following fertility treatments in the United States from 2011 to 2014. Heart. 2017 Nov 16.
  • Gandhi M, Hosseinzadeh P, Salmanian B, Moaddab A, Golabbakhsh H, Clarks SL, Shamshirsaz AA. Dietary consultation effect on weight gain in twin pregnancies. J Reprod Med. 2018 August; 63(4):347-51.

BOOK CHAPTER

  • Goldberg J.M, Arian S, Hosseinzadeh P. “Fertility Assessment in the Female”. In cancer and fertility,69-79.New York:Springer,2016.

  • Hosseinzadeh P, Woodard T. “Management of sexual dysfunction in female.” In Handbook of Gynecology,1-13.New York:Springer,2016.

Dr. Karl Hansen, Dr. LaTasha Craig, and Dr. Heather Burks, , your Board-Certified Reproductive Endocrinology and Infertility Subspecialists and the OU Physicians Reproductive Medicine team, including Michael T Zavy PhDDr. Blake Evans, Angela King, PAC  and REI Fellows: Sushila Arya, MD, Sarah Gavrizi, MD, and Pardis Hosseinzadeh, MD who proudly provide the complete scope of infertility treatments including:

In-vitro fertilization (IVF), Fertility Preservation (egg freezing), Laparoscopic and hysteroscopic surgery, Frozen (cryopreserved) embryo transfer, Ovulation induction, Intrauterine insemination, Donor insemination, Recipient / oocyte (egg) donation cycles, Hysterosalpingograms, Preimplantation Genetic Diagnosis, and Surrogacy / Gestational Carrier cycles

OU Physicians Reproductive Medicine
840 Research Parkway, Suite 200,
Oklahoma City, OK 73104
405-271-1616

 Other neighboring cities less than 90 minutes away include:Elk City, Weatherford, Ardmore, Pauls Valley, Chickasha, Lawton, Enid and Tulsa.
    Serving the Oklahoma City Area and the following Oklahoma cities:Guthrie, Yukon, El Reno, Norman, Stillwater, Shawnee,Bethany, Moore, Midwest City and Del City.


OU Physicians Reproductive Medicine Coronavirus Update

UPDATE: September 1, 2020 -- Here at OU Physicians Reproductive Medicine, we know that the last few months have been challenging as we all begin to understand the far reaching impact that COVID-19 has and we will continue to encounter a different set of challenges as we adjust to how we go about our daily lives while helping your achieve your dream of building a family. We are committed to that dream and committed to doing our part to stop the spread of COVID-19 by taking specific precautions during your visit to our fertility center:

  • We are engaged in social distancing by limiting the number of on-site guests to patients who are actively in-cycle;
  • We are ensuring that patient consults are staggered to minimize contact with other guests or patients during your visits;

OU Physicians Reproductive Medicine Visitation Policy

  • We are NOT ALLOWING visitors including: husbands, partners, parents, friends or children.  If you have questions please call our office at 405-271-1616.
  • Screening policies and procedures will be updated frequently and modified as needed by care setting.

Check-in entails the following questions:

  1. Have you traveled outside Oklahoma to a state or country with a high incidence of COVID-19 within the last 14 days?
  2. Have you had any of the following symptoms during the past 24 hours?
    • Fever ≥ 100° F
    • Cough
    • Shortness of Breath
    • Body Aches
  3. Have you been exposed to someone who is ill and traveled within the last 14 days?
  4. Have you had a known exposure to a person with suspected/confirmed COVID-19 (Coronavirus)?

These screening policies and procedures are subject to change as new information evolves.

 For more information on COVID-19, including resources, FAQs, and updates to visitation policies, visit www.oumedicine.com/coronavirus